UNSPSC 51101657: Etofamide

This classification denotes an antiprotozoal agent with the molecular formula C19H20Cl2N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03F36JH21U, chemically known as 2,2-dichloro-n-(2-ethoxyethyl)-n-(p-(p-nitrophenoxy)benzyl)acetamide but generally known as etofamide, which bears US NIH Compound Identifier 65718. European Medicines Agency schedules Etofamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07318MIG.

UNSPSC 51101657 Etofamide, a Commodity code, does not align with the state and local procurement activity recently tagged under it. The source shows no recent solicitations for etofamide or chemically related pharmaceuticals; instead, the tagged opportunities span naloxone procurement, therapeutic pharmacy initiatives, emergency medical supplies, and generic multi-source pharmaceuticals through cooperative purchasing — none of which target etofamide specifically. The code assignment appears to be a data-tagging error rather than a reflection of current buying patterns.

The mismatch between the code name and recent activity makes it difficult to characterize authentic market demand under this Commodity code. State and local governments are actively procuring naloxone, emergency medical consumables, and generic pharmaceuticals through direct bids and cooperative contracts, but these solicitations are tagged to broader pharmaceutical and medical-supply codes rather than to etofamide. No representative opportunities targeting this specific pharmaceutical are present in the recent record. Procurement professionals evaluating etofamide sales opportunities to state and local buyers should verify whether their target customers are actually sourcing this product through formal procurement channels, as current evidence suggests minimal or mislabeled activity under this code.